CBA-1535

CBA-1535 · Chiome Bioscience Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CBA-1535, covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. [Phase 1]

See pricing